Cantargia publishes interim report for first quarter 2022
Interim report for first quarter 2022 is now available on the company's web page...
Stay updated with breaking news from Systemic Sclerosis World. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interim report for first quarter 2022 is now available on the company's web page...
Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative...
—Translational Study Data Presented at 7th Systemic Sclerosis World Congress Confirms CCL24 is Elevated in Diffuse Cutaneous Systemic Sclerosis Patients; High...
—Translational Study Data Presented at 7th Systemic Sclerosis World Congress Confirms CCL24 is Elevated in Diffuse Cutaneous Systemic Sclerosis Patients; High...